Updates

24Jul

NIMBLE I

NIMBLE-I  We are excited to share that NIMBLE-I, our first-in-human clinical study, is now officially completed.   Fifty-six patients were enrolled at the Hospital Universitari Germans Trias i Pujol (Can Ruti) in Badalona, Spain, marking an important milestone in the journey of the WAEVE® System from laboratory prototype to clinical reality.  The Problem  Every year, hundreds of thousands of patients undergo coronary stent implantation to treat blocked arteries. While stents are life-saving, living with one is not without uncertainty. In-stent restenosis (ISR), the re-narrowing of the artery inside the stent, affects between 5% and 10% of all patients with a stent. Aside restenosis, stent fractures and other structural complications add …

NIMBLE Diagnostics CTO Susana Amorós: Leader of Innovation

NIMBLE Diagnostics has a strong collection of leaders steering its development and innovation as its technology succeeds expectations. Their CTO, Susana Amorós, sat down to discuss what brought her to the project, the next steps, and the inspiration that brought her to change lives. Amorós began her studies at UPC studying telecommunications engineering. However, during her last year, she discovered her passion — working in the medical sector of her field. With her degree, she would be able to aid in the design, testing, and manufacturing of medical equipment. Understanding …
nimble-diagnostics-cardiology-stent03Feb

Winner of Barcelona Activa Technology Grant

NIMBLE Diagnostics had recognition once more for its innovation and groundbreaking technology. This past week NIMBLE participated in and won first place in an accelerator program organized by Barcelona Activa and Grow Venture Partners. This program was created for early-stage technology projects, disruptive technologies, and technology in the validation stage in laboratory environments. NIMBLE competed against 7 selected projects and was judged by a panel of 4 experts, pushing the revolutionary technology to the final round where NIMBLE was judged by a panel of 19 professionals. After careful deliberation, NIMBLE was chosen for …
igtp-medicine-cardiac-stent15Ene

NIMBLE Diagnostics Closed Funding of Over 1 million Euros

Awarded 1.000.000 Euros NIMBLE Diagnostics’ funding has shown immense success. NIMBLE Diagnostics has successfully closed a funding round led by Grow Venture Partners together with Namarel Ventures and Inveniam Group. They have secured over 1 million euros to continue their mission of saving lives through preventative care. NIMBLE Diagnostics is a spin-off company of experts in the cardiology field of Germans Trias i Pujol Research Institute (IGTP), the Universitat Politècnica de Catalunya (UPC) – BarcelonaTech and the Universitat de Barcelona. They are all working together to create a medical technology device, the first of …
heart-stent-innovation15Nov

E-nnova Health 2022 Award Winner: NIMBLE Diagnostics

E-nnova Health Award NIMBLE Diagnostics was recognized once more for its innovation and revolutionary technology. At the Pablo XI Foundation in Madrid, Spain, CEO of NIMBLE Diagnostics Dr. Oriol Iborra Egea accepted the 2022 E-nnova Health Award in honor of NIMBLE’s innovation in medical technology and drive to save lives through preventative medicine. Follow us on LinkedIn to keep up to date on our transformative journey. …